The charts of Cytokinetics (CYTK) have caught my attention. Let's take a look at this late-stage bio-pharmaceutical company that is focused on muscle activators and inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.
More from Investing
The pizza chain's charts indicate there is still upside potential in its stock.
Home improvement and supply concerns and homebuilders should do well as the movement from big cities to smaller towns gains traction.
There has been some selling pressure of late, but it is not correlated and is trapping overzealous bears.
Interpreting the flow of capital in theory, or at least historically, for equities is quite simple. It's about growth, or the lack thereof.